Event Type: The company will be participating in one-to-one meetings with investors.
Date and Time: The meeting is scheduled for August 17, 2026. No specific time or time zone was mentioned in the disclosure.
Purpose: The meeting serves as general investor interaction and outreach.
Management Participants: The disclosure does not specify which company officials will be participating in the meetings.
Materials Availability: Relevant press releases and investor presentations proposed to be discussed are available on the company's website (www.fermentabiotech.com) and on BSE Limited's website (www.bseindia.com).
UPSI Compliance: The company explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.
Financial Disclosure: No financial data, results, guidance, or strategic updates were disclosed in this announcement.
Additional Notes Section
Format and Location: The meetings will be conducted in physical mode in Mumbai.
Contingency Note: The disclosure notes that changes may happen due to exigencies on the part of the company or investors.
Regulatory Reference: This intimation is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
